Tradestie Institutional Equity Comparison Engine

AXNX vs AHCO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AHCO Overall Edge

AHCO Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AdaptHealth Corp. Common Stock (AHCO) driven by superior Valuation, Growth & Margin, Options & Structure while AXNX counters with relative strength in Momentum & Technical. Fundamentally, AXNX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus AHCO at 7.8x Forward P/E and 3.8% operating margin (+10.9% YoY). In options structure, AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AHCO sits in SURGE (12th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AHCO
AXNX N/M vs AHCO 7.8x Fwd P/E
Growth & Margin Winner AHCO
Op Margin N/A vs 3.8% ยท YoY N/A vs +10.9%
Momentum & Technical Winner AXNX
1Y +16.9% vs -20.9% ยท 52W Pos 50% vs 24%
Options & Structure Winner AHCO
UNCLASSIFIED (N/A IV) vs SURGE (12th %ile IV)
AXNX US Equity
AXNX
Institutional Equity
$0.83
-8.28% 1D
Market Cap N/A
1M Return -26.54%
1Y Return +16.92%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
AHCO NASDAQ
AdaptHealth Corp. Common Stock
Services-Home Health Care Services
$7.20
-0.69% 1D
Market Cap $989.8M
1M Return +16.69%
1Y Return -20.88%
Forward P/E 7.8x
Unified AI Score
45.2 / 100 HOLD
Tech 29.0 Fund 46.0 Flow 54.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AXNX +16.92% AHCO -20.88% Spread: +3.18 pp (AXNX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AXNX TTM Op. Margin: N/A AHCO TTM Op. Margin: 3.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXNX vs AHCO. Trailing 12-month operating profitability (AXNX N/A vs AHCO 3.8%) and valuation multiples (AXNX N/M vs AHCO 7.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AXNX (2) vs AHCO (8)
Institutional Metric AXNX AHCO Criterion Row Winner
Market Capitalization Scale N/A $989.8M Larger Scale AHCO
Trailing P/E Ratio Valuation N/M 7.8x Lower Multiple AHCO
Forward P/E Ratio Valuation N/M 7.8x Lower Multiple AHCO
Revenue Growth (YoY) Growth N/A +10.9% Higher Growth AHCO
Operating Margin (TTM) Profitability N/A 3.8% Higher Margin AHCO
Net Profit Margin Profitability N/A -11.8% Higher Margin AHCO
Return on Equity (ROE) Capital Efficiency N/A -28.4% Higher ROE AHCO
52-Week Range Position Momentum 50% ($0โ€“$1) 24% ($5โ€“$13) Stronger Trend AXNX
Beta / 30D Volatility Risk Regime N/A 0.17ฮฒ ยท 67% Vol Lower Realized Risk AHCO
Unified Institutional Score Composite Signal 52.1 / 100 (HOLD) 45.2 / 100 (HOLD) Higher Composite AXNX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AXNX vs AHCO Buy Guide
AXNX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AXNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AHCO SURGE
6d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live AHCO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AXNX nor AHCO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.